Abstract
The rising prevalence of obesity is accompanied by an increasing number of patients with the metabolic complications of obesity. The major complications come under the heading of the metabolic syndrome. This syndrome is characterized by plasma lipid disorders (atherogenic dyslipidemia), raised blood pressure, elevated plasma glucose, and a prothrombotic state. The clinical consequences of the metabolic syndrome are coronary heart disease and stroke, type 2 diabetes and its complications, fatty liver, cholesterol gallstones, and possibly some forms of cancer. At the heart of the metabolic syndrome is insulin resistance, which represents a generalized derangement in metabolic processes. Obesity is the predominant factor leading to insulin resistance, although other factors play a role. The mechanistic link between insulin resistance and the metabolic syndrome is complex. The relationship is modulated by yet other factors, such as physical activity, body fat distribution, hormones, and a person's genetic polymorphic architecture. A better understanding of the molecular basis of this relationship is needed to suggest new targets for prevention and treatment of the complications of obesity. In addition, understanding at the clinical level will lead to improved management of these complications.
Similar content being viewed by others
References
Must, A. J., Spadano, J., Coakley, E. H., Field, A. E., Colditz, G., and Dietz, W. H. (1999). JAMA 282, 1523–1529.
National Institutes of Health. (1998). Obes Res. 2, 51S-209S.
Keys, A., Menotti, A., Aravanis, C., et al. (1984). Prev. Med. 13, 141–154.
Montenegro, M. R., and Solberg, L. A. (1968). Lab. Invest. 18, 594–603.
Bjorntorp, P. (1985). Am. Clin. Res. 17, 3–9.
Despres, J. P., Moorjani, S., Lupien, J. P., Tremblay, A., Nadeau, A., and Bouchard, C. (1990). Arteriosclerosis. 10, 497–511.
Garrison, R. J., Higgins, M. W., and Kannel, W. B. (1996). Curr. Opin. Lipidol. 7, 199–202.
Williams, S. R., Jones, E., Bell, W., Davies, B., and Bourne, M. W. (1997). Eur. Heart J. 18, 376–393.
Wilson, P. W. F., D'Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., and Kannel, W. B. (1998). Circulation 97, 1837–1847.
Eckel, R. H. (1997). Circulation 96, 3248–3250.
Visser, M., Bouter, L. M., McQuillan, G. M., Wener, M. H., and Harris, T. B. (1999). JAMA 282, 2131–2135.
Reaven, G. M., and Olefsky, J. M. (1978). Adv. Metab Disord. 9, 313–331.
Bogardus, C., Lillioja, S., and Mott, D. (1984). J. Clin. Invest. 73, 800–805.
Abate, N., Garg, A., Peshock, R. M., Stray-Gundersen, J., and Grundy, S. M. (1995). J. Clin. Invest. 96, 88–98.
Polonsky, K. S. (1999). Exp. Clin. Endocrinol. Diabetes 107(Suppl 4), S124-S127.
Lebovitz, H. E. (1999). Clin. Chem. 45(8 Pt.2) 1339–1345.
Boden, G. (1998). Front. Biosci. 3, D169-D175.
Jeng, C. Y., Sheu, W. H., Fuh, M. M., Chen, Y. D., and Reaven, G. M. (1994). Diabetes 43, 1440–1444.
Maheux, P., Chen, Y. D., Polonsky, K. S., and Reaven, G. M. (1997). Diabetologia 40, 1300–1306.
Randle, P. J., Garland, P. B., Hales, C. N., and Newsholme, E. A. (1963). Lancet I, 785–789.
Boden, G., Chen, X., Ruiz, J., White, J. V., and Rossetti, L. 1994. J. Clin. Invest. 93, 2438–2446.
Randle, P. J., Priestman, D. A., Mistry, S. C., and Halsall, A. (1994). J. Cell. Biochem. 55, 1–11.
Randle, P. J., Priestman, D. A., Mistry, S. C., and Halsall, A. (1994). Diabetologia 37, S155-S161.
Wolfe, R. R. (1998). Am. J. Clin. Nutr. 67, 519S-526S.
Shulman, G. I. (1999). Am. J. Cardiol. 84, 3J-10J.
Ebeling, P., Koistinen, H. A., and Koivisto, V. A. (1998). FEBS Lett. 436, 301–303.
Kahn, B. B. (1996). Diabetes 45, 1644–1654.
Rea, S., and James, D. E. (1997). Diabetes 46, 1667–1677.
Cushman, S. W., Goodyear, L. J., Pilch, P. F., Ralston, E., Galbo, H., Ploug, T., Kristiansen, S., and Klip, A. (1998). Adv. Exp. Med. Biol. 441, 63–71.
Schreyer, S. A., Chua, S. C. Jr., and LeBoeuf, R. C. 1998. J. Clin. Invest. 102, 402–411.
Halle, M., Berg, A., Northoff, H., and Keul, J. (1998). Exerc. Immunol. Rev. 4, 77–94.
Donnelly, R., and Qu, X. (1998). Clin. Exp. Pharmacol. Physiol. 25, 79–87.
Roth, R. A., Liu, F., and Chin, J. E. (1994). Horm. Res. 41, S51-S55.
Stein, D. T., Esser, V., Stevenson, B. E., Lane, K. E., Whiteside, J. H., Daniels, M. B., Chen, S., and McGarry, J. D. (1996). J. Clin. Invest. 97, 2728–2735.
Bollheimer, L. C., Skelly, R. H., Chester, M. W., McGarry, J. D., and Rhodes, C. J. (1998). J. Clin. Invest. 101, 1094–1101.
Dobbins, R. L., Chester, M. W., Stevenson, B. E., Daniels, M. B., Stein, D. T., and McGarry, J. D. (1998). J. Clin. Invest. 101, 2370–2376.
Dobbins, R. L., Chester, M. W., Daniels, M. B., McGarry, J. D., and Stein, D. T. (1998). Diabetes 47, 1613–1618.
Jensen, M. D., Haymond, M. W., Rizza, R. A., Cryer, P. E., and Miles, J. M. (1989). J. Clin. Invest. 83, 1168–1173.
Coppack, S. W., Jensen, M. D., and Miles, J. M. (1994). J. Lipid Res. 35, 177–193.
Jensen, M. D. (1997). Annu. Rev. Nutr. 17, 127–139.
Meek, S. E., Nair, K. S., and Jensen, M. D. (1999). Diabetes 48, 10–14.
Fujimoto, W. Y., Bergstrom, R. W., Boyko, E. J., Leonetti, D. L., Newell-Morris, L. L., and Wahl, P. W. (1995). Obes. Res. 3(2), 179s-186s.
Despres, J. P. (1998). Obes. Res. 6(Suppl 1), 8S-17S.
Bolinder, J., Engfeldt, P., Ostman, J., and Arner, P. (1983). J. Clin. Endocrinol. Metab. 57, 455–461.
Engfeldt, P., Bolinder, J., Ostman, J., and Arner, P. 1985. J. Clin. Endocrinol. Metab. 868–873.
Goudas, V. T., and Dumesic, D. A. (1997). Endocrinol. Metab. Clin. North Am. 26, 893–912.
Pasquali, R., Gambineri, A., Anconetani, B., Vieennati, V., Colitta, D., Caramelli, E., and Morselli-Labate, A. M. (1999). Clin. Endocrinol. 50, 517–527.
Rebuffe-Scrive, M., Marin, P., and Bjorntorp, P. (1991). Int. J. Obest. 15, 791–795.
Bjorntorp, P. (1996). Int. J. Obes. Relat. Metab. Disord. 20, 291–302.
Bouchard, C. (1997). Hum. Reprod. 12(Suppl 1), 1–5.
Katzmarzyk, P. T., Perusse, L., Rao, D. C., and Bouchard, C. (1999). Am. J. Epidemiol. 149, 933–942.
Chandalia, M., Abate, N., Garg, A., Stray-Gundersen, J., and Grundy, S. M. (1999). J. Clin. Endocrinol. Metab. 84, 2329–2335.
Hughes, K., Aw, T. C., Kuperan, P., and Choo, M. (1997). J. Epidem. Comm. Health 51, 394–399.
Reaven, G. M. (1991). Am. Heart J. 121, 1283–1288.
Starke, A. A. (1994). Wien. Klin. Wochenschr. 106, 768–773.
Hayashi, T., Wojtaszewski, J. F., and Goodyear, L. J. (1997). Am. J. Physiol. 273, E1039-E1051.
Goodyear, L. J., and Kahn, B. B. (1998). Annu. Rev. Med. 49, 235–261.
Perseghin, G., Price, T. B., Petersen, K. F., Roden, M., Cline, G. W., Gerow, K., Rothman, D. L., and Shulman, G. I. (1996). N. Engl. J. Med. 335, 1357–1362.
Eaton, S., Record, C. O., and Bartlett, K. (1997). Eur. J. Clin. Invest. 27, 719–722.
Baraona, E. and Lieber, C. S. (1998). Recent Dev. Alcohol 14, 97–134.
Van Steenbergen, W., and Lanckmans, S. (1995). Int. J. Obes. Relat. Metab. Disord. 19(Suppl 3), S27-S36.
Brolin, R. E., Bradley, L. J., and Taliwal, R. V. (1998). Arch. Surg. 133, 84–88.
Diehl, A. M. (1999). Semin. Liver Dis. 19, 221–229.
Robertson, D. A., Singh, B. M., and Nattrass, M. (1991). Int. J. Obes. 15, 635–645.
Krentz, A. J., Singh, B. M., Hale, P. J., Robertson, D. A., and Nattrass, M. (1992). Diabetes Res. 20, 51–60.
Grundy, S. M., Mok, H. Y., Zech, L., Steinberg, D., and Berman, M. (1979). J. Clin. Invest. 63, 1274–1283.
Grundy, S. M. (1980). In: Atherosclerosis V. Gotto, A. M., Smith, L. C., and Allen, B. (eds.) Springer Verlag: New York.
Boren, J., White, A., Wettesten, M., Scott, J., Graham, L., and Olofsson, S. O. (1991). Prog. Lipid Res. 30, 205–218.
Kesaniemi, Y. A., Beltz, W. F., and Grundy, S. M. (1985). J. Clin. Invest. 76, 586–595.
Egusa, G., Beltz, W. F., Grundy, S. M., and Howard, B. V. (1985). J. Clin. Invest. 76, 596–603.
Li, X., Grundy, S. M., and Patel, S. B. (1997). J. Lipid Res. 38, 1277–1288.
Okosun, I. S., Prewitt, T. E., Liao, Y., and Cooper, R. S. (1999). Int. J. Obes. Relat. Metab. Disord. 23, 498–504.
Morrison, J. A., Sprecher, D. L., Barton, B. A., Waclawiw, M. A., and Daniels, S. R. (1999). J. Pediatr. 135(4), 458–464.
Denke, M. A., Sempos, C. T., and Grundy, S. M. (1993). Arch. Intern. Med. 153, 1093–1103.
Wolf, R. N., and Grundy, S. M. (1983). Arteriosclerosis 3, 160–169.
Li, W. W., Dammerman, M. M., Smith, J. D., Metzger, S., Breslow, J. L., and Leff, T. (1995). J. Clin. Invest. 96, 2601–2605.
Zambon, A., Deeb, S. S., Hokanson, J. E., Brown, B. G., and Brunzell, J. D. (1998). Arterioscler. Thromb. Vasc. Biol. 18, 1723–1729.
Nie, L., Wang, J., Clark, T. J., Tang, A., Vega, G. L., Grundy, S. M., and Cohen, J. C. (1998). J. Lipid Res. 39, 1127–1130.
Grundy, S. M. (1995). Am. J. Cardiol. 75, 45B-52B.
Everhart, J. E. (1993). Ann. Intern. Med. 119, 1029–1035.
Hofmann, A. F. (1988). J. Clin. Gastroenterol. 10(Suppl 2), S1-S11.
Nestel, P. J., Schreibman, P. H., and Ahrens, E. H., Jr. (1973). J. Clin. Invest. 52, 2389–2397.
Grundy, S. M., Metzger, A. L., and Adler, R. D. (1972). J. Clin. Invest. 51, 3026–3043.
Grundy, S. M., Duane, W. C., Adler, R. D., Aron, J. M., and Metzger, A. L. (1974). Metabolism 23, 67–73.
Hall, J. E., Brands, M. W., Jones, D. W., Shek, E. W., and Henegar, J. (1999). In: Obesity: impact on cardiovascular disease. Fletcher, G. F., Grundy, S. M., and Hayman, L. L. (eds.). Futura: Armonk, NY.
Hollenberg, N. K. (1996) Curr. Opin. Cardiol. 11, 457–463.
Caulfield, M., Collier, D., and O'Byrne, S. (1998) Hosp. Med. 59, 37–40.
Lifton, R. P. (1995) Proc. Natl. Acad. Sci. USA 92, 8545–8551.
Scherrer, U., Owlya, R., and Lepori, M. (1996) Cardiovasc. Drugs Ther. 10(Suppl 1), 215–222.
Landsberg, L. (1996) Clin. Exp. Hypertens 18, 337–346.
Brands, M. W., Hall, J. E., and Keen, H. L. (1998) Clin. Exp. Pharmacol. Physiol. 25, 70–76.
Hall, J. E., Brands, M. W., Henegar, J. R., and Shek, E. W. (1998) Clin. Exp. Pharmacol. Physiol. 25, 58–64.
Crisostomo, L. L., Araujo, L. M., Camara, E., Carvalho, C., Silva, F. A., Vieira, M., and Rabelo, A. Jr. (1999) Am. J. Cardiol. 84, 1127–1129.
Okin, P. M., Jern, S., Devereux, R. B., Kjeldsen, S. E., and Dahlof, B. (2000) Hypertension 35(1 Pt1), 13–18.
Palatini, P. (1999) J. Hypertens. 17(Suppl 3), S3-S10.
Gensini, G. F., Comeglio, M., and Colella, A. (1998) Eur. Heart J. 19(Suppl A), A53-A61.
Meigs, J. B., Mittleman, M. A., Nathan, D. M., Tofler, G. H., Singer, D. E., Murphy-Sheehy, P. M., Lipinska, I., D'Agostino, R. B., and Wilson, P. W. (2000) JAMA 283, 221–228.
Juhan-Vague, I. and Alessi, M. C. (1997) Thromb. Heamost. 78, 656–660.
De Pergola, G., De Mitrio, V., Giorgino, F., Sciaraffia, M., Minenna, A., Di Bari, L., Pannacciulli, N., and Giorgino, R. (1997) Int. J. Obes. Relat. Metab. Disord. 21, 527–535.
De Lorenzo, F., Mukherjee, M., Kadziola, Z., Suleiman, S., and Kakkar, V. V. (1998) Thromb. Haemost. 80, 603–606.
Cook, D. G., Wincup, P. H., Miller, G., Carey, I. M., Adshead, F. J., Papacosta, O., Walker, M., and Howarth, D. (1999) Am. J. Epidemiol. 150, 727–736.
Eriksson, P., Reynisdottir, S., Lonnqvist, F., Stemme, V., Hamsten, A., and Arner, P. (1998) Diabetologia 41, 65–71.
Cigolini, M., Tonoli, M., Bargato, L., Frigotto, L., Manzato, F., Zeminian, S., Cardinale, C., Camin, M., Chiaramonte, E., De Sandre, G., and Lunardi, C. (1999) Atherosclerosis 143, 81–90.
Halleux, C. M., Declerck, P. J., Tran, S. L., Detry, R., and Brichard, S. M. (1999) J. Clin. Endocrinol. Metab. 84, 4097–4105.
Crandall, D. L., Quinet, E. M., Morgan, G. A., Busler, D. E., McHendry-Rinde, B., and Kral, J. G. (1999) J. Clin. Endocrinol. Metab. 84, 3222–3227.
Morange, P. E., Alessi, M. C., Verdier, M., Casnova, D., Magalon, G., and Juhan-Vague, I. (1999) Arterioscler. Thromb. Vasc. Biol. 19, 1361–1365.
Pujol, P., Galtier-Dereure, F., and Bringer, J. (1997) Hum. Reprod. 12(Suppl 1), 116–125.
Carroll, K. K. (1998) Lipids 33, 1055–1059.
Hill, M. J. (1999) Public Health Nutr. 2, 397–401.
Tominaga, S. (1999) Cancer Lett. 143(Suppl 1), S19-S23.
Gerber, M. and Corpet, D. (1999) Eur. J. Cancer Prev. 8, 77–89.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grundy, S.M. Metabolic complications of obesity. Endocr 13, 155–165 (2000). https://doi.org/10.1385/ENDO:13:2:155
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:13:2:155